Tiansheng Pharmaceutical Group Co Ltd

002872 · SHE · Healthcare / Biotechnology

5.81CNY-0.22 (-3.65%)

Price History

Full chart

Market Stats

Previous Close6.03

Open6.04

Day Range5.78 – 6.04

52-Week Range4.32 – 6.28

Volume4.61M

Market Cap1.98B

P/E (TTM)0.00

Forward P/E0.00

EPS-0.13

Dividend Yield0.00%

Beta0.35

50-Day Avg5.49

200-Day Avg5.19

About

Tiansheng Pharmaceutical Group Co., Ltd. engages in pharmaceutical manufacturing and circulation activities. The company offers pediatric cough granules, erythromycin enteric-coated capsules, yinshen tongluo capsules, yanshen jianwei capsules, and sodium chloride injection products. It provides products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, pediatrics, digestive, gynecological, orthopedic, cardiology, diabetes, anesthetic, oncology, hepatobiliary, hematological, surgical, and others. In addition, it provides traditional Chinese medicines and glucose injection. Tiansheng Pharmaceutical Group Co., Ltd. was founded in 2001 and is headquartered in Chongqing, China.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Shuang Liu
Employees1.27K
HeadquartersChaoyang Industrial Park, Chongqing, China, 408300, China
Websitehttps://www.tszy.com.cn

Leadership

Mr. Shuang LiuChairman of the Board & GM · b. 1993
Mr. Kai Sheng WangCFO & Accounting Supervisor · b. 1974
Mr. Zonghua TanDeputy GM & Director · b. 1972
Ms. Qin WangBoard Secretary · b. 1985
Mr. Lun Sheng MouDeputy General Manager · b. 1976

Financials

Income Statement

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.00B	1.42B	1.66B	1.84B	2.09B	2.26B	2.17B	1.68B	1.20B	736.69M	606.99M	579.33M	569.71M	514.09M
Growth (%)	-	+41.61%	+17.01%	+10.77%	+13.23%	+8.36%	-3.98%	-22.65%	-28.39%	-38.75%	-17.61%	-4.56%	-1.66%	-9.76%
Cost of Revenue	716.86M	1.00B	1.22B	1.33B	1.49B	1.59B	1.56B	1.27B	873.30M	441.56M	279.10M	322.36M	308.57M	261.59M
Gross Profit	287.26M	421.44M	447.67M	514.43M	595.65M	666.66M	615.02M	414.22M	329.44M	295.12M	327.89M	256.97M	261.14M	252.50M
Gross Margin	28.61%	29.64%	26.91%	27.91%	28.54%	29.48%	28.32%	24.66%	27.39%	40.06%	54.02%	44.36%	45.84%	49.12%
Operating Expense	163.80M	271.81M	274.32M	307.51M	357.93M	358.25M	554.30M	635.87M	829.79M	356.11M	412.59M	350.55M	355.17M	290.73M
Operating Income	123.46M	149.63M	173.34M	206.92M	237.72M	308.42M	60.73M	-221.65M	-500.34M	-60.99M	-84.71M	-93.57M	-94.03M	-38.23M
Operating Margin	12.30%	10.52%	10.42%	11.23%	11.39%	13.64%	2.80%	-13.20%	-41.60%	-8.28%	-13.96%	-16.15%	-16.50%	-7.44%
EBITDA	165.58M	244.85M	296.07M	343.87M	388.21M	428.75M	187.73M	-84.39M	-378.64M	58.75M	37.17M	24.53M	22.67M	71.57M
EBITDA Margin	16.49%	17.22%	17.80%	18.66%	18.60%	18.96%	8.65%	-5.02%	-31.48%	7.97%	6.12%	4.23%	3.98%	13.92%
Net Income	109.99M	125.95M	164.57M	191.98M	224.50M	247.33M	8.86M	-223.98M	-490.73M	-67.81M	-90.56M	-93.07M	-87.40M	-55.42M
Net Income Margin	10.95%	8.86%	9.89%	10.42%	10.76%	10.94%	0.41%	-13.34%	-40.80%	-9.20%	-14.92%	-16.07%	-15.34%	-10.78%
R&D	14.68M	25.15M	19.13M	21.18M	35.12M	33.86M	39.78M	36.29M	22.46M	29.24M	34.27M	30.92M	22.75M	22.32M
R&D as % of Total Revenue	1.46%	1.77%	1.15%	1.15%	1.68%	1.50%	1.83%	2.16%	1.87%	3.97%	5.65%	5.34%	3.99%	4.34%
Interest Expense	17.65M	26.60M	38.53M	35.08M	37.24M	29.55M	42.18M	39.38M	38.89M	25.84M	15.78M	15.08M	14.78M	11.25M
Interest Expense % of Total Revenue	1.76%	1.87%	2.32%	1.90%	1.78%	1.31%	1.94%	2.34%	3.23%	3.51%	2.60%	2.60%	2.59%	2.19%

Balance Sheet

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.74B	2.16B	2.50B	2.87B	3.39B	4.95B	4.67B	4.39B	3.65B	3.12B	2.97B	2.81B	2.74B	2.64B
Total Liabilities	792.28M	1.08B	1.06B	1.24B	1.53B	1.76B	1.49B	1.44B	1.26B	840.79M	782.23M	715.25M	721.80M	685.37M
Total Equity	923.25M	1.04B	1.39B	1.58B	1.81B	3.13B	3.11B	2.90B	2.34B	2.27B	2.18B	2.09B	2.01B	1.95B
Cash	136.38M	174.53M	166.65M	201.00M	418.96M	606.27M	327.28M	318.16M	291.73M	338.68M	278.25M	192.71M	270.42M	280.47M
Total Debt	259.77M	457.56M	477.46M	586.90M	666.10M	843.23M	688.70M	624.70M	494.44M	350.87M	267.59M	176.40M	277.07M	-
Net Debt	123.40M	283.03M	310.81M	385.90M	247.14M	236.96M	361.42M	306.54M	202.71M	12.19M	-10.66M	69.61M	6.65M	-

Cash Flow

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	145.06M	57.06M	191.99M	213.54M	506.68M	-55.75M	153.99M	144.21M	189.75M	18.97M	89.18M	-24.56M	50.15M	42.97M
Investing Cash Flow	-152.04M	-184.10M	-360.91M	-255.33M	-394.11M	-954.19M	-160.90M	-128.56M	-76.15M	169.58M	-65.57M	-82.08M	5.57M	-
Financing Cash Flow	40.90M	167.63M	186.57M	79.65M	68.59M	1.23B	-273.61M	-33.79M	-134.57M	-138.97M	-44.47M	-11.20M	50.56M	-
Capital Expenditure	184.63M	126.34M	330.32M	274.87M	425.96M	862.25M	234.27M	93.24M	92.70M	114.38M	73.42M	76.74M	50.27M	26.92M
Free Cash Flow	-39.57M	-69.29M	-138.33M	-61.33M	80.72M	-918.00M	-80.28M	50.97M	97.05M	-95.41M	15.76M	-101.30M	-125.70K	16.05M
Dividends Paid	19.40M	29.55M	37.24M	31.10M	35.98M	34.34M	93.01M	34.75M	37.19M	22.89M	15.94M	15.54M	15.26M	14.97M
FCF to OCF	-27.28%	-121.43%	-72.05%	-28.72%	15.93%	1646.67%	-52.14%	35.34%	51.15%	-502.91%	17.67%	412.43%	-0.25%	37.36%
Dividend Paid to FCF	-49.02%	-42.65%	-26.92%	-50.70%	44.58%	-3.74%	-115.86%	68.18%	38.32%	-24.00%	101.11%	-15.34%	-12138.83%	93.27%

Earnings

Report Date	Aug 21, 2017	Oct 22, 2017	Dec 31, 2017	Apr 22, 2018	Jun 30, 2018	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Apr 28, 2020	Aug 26, 2020	Oct 28, 2020	Dec 31, 2020	Apr 27, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	May 16, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	May 16, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.14	0.18	-0.02	0.21	0.14	0.11	-0.11	0.03	-0.01	-0.22	-0.50	-0.03	-0.19	-0.16	-1.17	-0.08	-0.05	-0.09	0.00	-0.05	-0.10	-0.05	-0.09	-0.05	-0.11	-0.10	-0.04	-0.06	-0.07	0.02	-0.16	-0.04	-0.08	-0.03	-0.03	-0.03	-0.05
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	Pre-market	After-hours	-	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	-	-	-	After-hours	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.98B

Enterprise Value1.95B

Trailing P/E0.00

Forward P/E0.00

Price / Sales3.84

Price / Book0.98

EPS-0.13

Book Value6.06

Revenue (TTM)514.89M

Gross Profit (TTM)237.76M

EBITDA74.06M

Profit Margin-8.33%

Operating Margin-20.19%

Return on Equity-2.24%

Return on Assets-1.09%

Shares Outstanding318.00M

Shares Float209.17M

Beta0.35

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20181×

0.16Aug 22, 2018

Stock Splits

Aug 22, 20181.5:1